New Delhi, October 26th, 2012
The NHRC has constituted an expert committee for framing of some guidelines for clinical trials of drugs in the country. The Commission took this decision in connection with some cases it registered suo motu on the basis of media reports alleging unethical clinical drug trials in the country. It had also received some complaints on the issue. The NHRC has also decided to intervene in the case relating to the clinical trials of drugs pending before the Supreme Court. The case has been filed as public interest litigation by an Indore based NGO, Swasthya Adhikar Manch.

The committee will comprise of the following:-

" Dr. D.C. Doval, Director Research & Director, Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi;
" Prof. Vivekanand Jha, Department of Nephrology, PGIMER, Chandigarh;
" Prof. B.N. Dhawan, former Director, Central Drug Research Institute, Lucknow and Chairman, Institutional Ethics Committee of Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow;
" Dr. Subhash Yadav, Addl. Professor, Department of Endocrinology & Member Secretary, IEC, SGPGI, Lucknow;
" Dr. Nilima Kshirsgar, National Chair in Clinical Pharmacology, Indian Council of Medical Research;
" Dean, ESI- PGIMER, MGM Hospital, Mumbai Law Division.

The NHRC shall coordinate the meetings of the Committee.

*****